Durable response to BRAF inhibitor monotherapy in recurrent metastatic low grade serous ovarian cancer

• Asıl Yazarlar: Shashank Sama (Yazar), Sterling Rosqvist (Yazar), Talicia Savage (Yazar), Lesley Lomo (Yazar), Kiera Sibbald (Yazar), Alli Straubhar (Yazar), Theresa L. Werner (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Elsevier, 2024-06-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Low grade serous ovarian cancers (LGSOC) in an advanced setting have limited systemic treatment options. In this paper we report a case of metastatic LGSOC harboring a BRAF mutation, treated with dabrafenib. We discuss the clinical, pathologic and molecular characteristics as well as surgical consid...